Scott Murano

Wilson Sonsini Goodrich & Rosati

+ Follow Contact

Latest Posts › Intellectual Property Protection

Share:

The Life Sciences Report – June 2025

This latest edition features articles on succeeding in the current life sciences funding market, strategic and legal considerations in digital health combinations, the corporate practice of medicine and guidance for...more

6/4/2025 / Digital Health , Healthcare , Intellectual Property Protection , Investment , Life Sciences , Patents , Pharmaceutical Industry , Regulatory Requirements , Venture Capital

The Life Sciences Report – January 2025

This latest edition features an interview with retiring longtime Wilson Sonsini IP partner Vern Norviel and articles on MedTech and pharma trends for 2025, the eligibility of life sciences companies for qualified small...more

1/9/2025 / Brand , Initial Public Offering (IPO) , Intellectual Property Protection , Life Sciences , Medical Devices , Patents , Pharmaceutical Industry , Regulatory Reform , Venture Capital

The Life Sciences Report – June 2022

Wilson Sonsini is pleased to present the latest edition of The Life Sciences Report. This issue features articles on the firm’s new Boulder office and recent Gateway to Colorado VC roadshow, a collaboration between Deloitte’s...more

6/14/2022 / FDA Approval , Food and Drug Administration (FDA) , Intellectual Property Protection , Life Sciences , Patent Litigation , Patents , Pharmaceutical Industry

The Life Sciences Report – January 2022

Wilson Sonsini is pleased to present the latest edition of The Life Sciences Report. This issue features an interview with Foresight Diagnostics co-founder and CEO Jake Chabon conducted by Matthew Meyer, the firm’s Chief...more

1/25/2022 / Antitrust Litigation , Antitrust Violations , Food and Drug Administration (FDA) , Intellectual Property Protection , Life Sciences , Medical Devices , Patents , Pharmaceutical Industry

4 Results

View per page

Page: of 1